Skip to main content
. 2018 Mar 6;12:1–7. doi: 10.1016/j.ctro.2018.03.001

Table 1.

Overview of the number of patients, radiation dose, and follow-up for each article included in the systematic review.

Author Primary/recurrence (%/%) Tumor location (%) Surgery Surgery + RT RT Observation Radiation dose (range) Gy Median FU (months)
Bonvalot S [7] 100 (primary) abd/chest wall (42), LE (23), UE (7), HN (14), trunk (14) 67 13 50 (4–60) S + RT 76
Stoeckle E [8] 65/35 92 7 50 (20–60) S + RT 123
El-Haddad [9] 48/52 E (52), trunk (39), HN (9) 6 41 4 3 50.4 (45–60) S + RT 88
Husain Z [10] LE (20), UE (40), buttock (10), Trunk (20), HN (10) 10 50.7 (44–62) S + RT 48
Huang K [11] 75/25 abd wall (50), LE (18), trunk (11), HN (18), UE (3) 106 25 (45–55) S + RT 102
Ballo MT [12] 45/55 abd wall (10), HN (10), trunk (44), buttock (5), UE (18), LE (13) 122 46 21 60
55
S + RT
RT
113
Gronchi A [13] 63/27 abd wall (22), trunk (50), LE (12), UE (8), HN (8) 172 40 57 (45–65) S + RT 135
Duggal A [14] 71/29 UE (34), LE (20), trunk (31), abd wall (3), buttock (12) 27 8 50 (10–64) S + RT 68*
Gluck I [15] 76/24 trunk (57), E (13), HN (20), abd/pelvis (10) 54 28 13 56 (50–68)
50 (50–59)
S + RT
RT
JelinekJA [16] abd (17), E (83) 19 35 54 S + RTa 38
Park HC [17] E (36), HN (16), trunk (32), buttocks (16) 21 3 48 (40–59) S + RT, RT 39*
Lev D [18] 74/26 UE (14), LE (16), abd wall (16), trunk (27), intra abd (14), retroperitoneal (6), HN (7) 94 35 9 (50–56) S + RT, RT 69
Phillips SR [19] 73/27 abd wall (21), HN (4), trunk (42), UE (9), LE (17) buttock (7) 73 2 18 (30–72) S + RT, RT 63
Mankin HJ [20] UE (7), LE (48), trunk (34), abd wall/pelvis (11) 185 39 31
Dalen BP [21] abd wall (24), UE (22), LE (22), trunk (31), HN (1) 29 1
Zlotecki RA [22] 42/58 UE (42), LE (35), trunk (7), abd (11), HN (5) 65c 54 (50–56) S + RT, RT 72
Barbier O [23] 42/58 UE (31), LE (58), buttock (11) 26 16*
Baumert BG [24] 60/40 42 68 59 (3–74) S + RT 72
Fiore M[6] 65/35 E (33), trunk (17), HN (4), abd wall (40), intra abd (7) 83 33
Merchant NB [25] 100 (primary) E (49), trunk (23), abd wall (20), HN(8) 74 31 (45–65) S + RTb 49
Nakayama T [26] 82/18 abd wall (18), UE (9), HN (18), LE (46), trunk (9) 2 9 56
Pajaras B [27] 90/10 abd wall (45), intra abd (15), UE (15), HN (10), LE (10), trunk (5) 17 2 50 (50) S + RT 35
Pignatti G [28] 42/58 UE (30), LE (60), trunk (8), other (2) 63 17 0 1 (35–66) S + RT 134*
Schulz-Ertner D [29] 43/57 HN (8), UE (25), LE (29), abd wall (10), intra abd (10), trunk (18) 26 2 48 (36–60) RTb 46
Sharma V [30] 88/12 E (45), HN (14), Trunk (14), abd (27) 15 15 4 8 60 (9–70)
50 (40–50)
S + RT
RT
Shido Y [31] trunk (30), UE (13), LE + buttock (57) 30 89
Sorensen A [32] abd(30), extra abd (70) 44 28 96
Guney Y [33] UE (29), LE (29), HN (14), buttock (14), trunk (14) 4 3 51 (50–62)
50 (40–50)
S + RT
RT
16
Rudiger HA [34] 59/41 UE (31), LE (43), trunk (26) 17 17 50 (24–60) S + RT 51*
Chew C [35] 36/64 UE (43), LE (40), HN (17) 40 1 1 150
Kriz [36] 48/52 E (54) trunk (38) abd wall (8) 37 15 50–60
55–65
S + RT
RT
44
Zeng [1] 67/33 abd wall (27) intra abd (11) trunk (18) E (14) HN (25) buttock (4) 184 39 38–66 S + RT 54
Prodinger [37] UE (49) LE (51) 10 17 50–60 S + RT 65
Shin [38] 74/26 trunk/HN (41) E (59) 95 24 38–70 S + RT 82*
Sri ram [39] UE (10) HN (23) trunk (18) buttock (14) LE (35) 48 19 5 48
Keus [40] 61/39 UE (32) LE (32) HN (2) trunk (23) abd wall (11) 44 56 RT 60
Ergen [41] 20/80 UE (20) LE (45) trunk (20) intra abd (10) HN (5) 18 2 60 (40–64) S + RT 77.5

RT = Radiotherapy, S = Surgery, FAP = Familial Adenomatous Polyposis FU: Follow-Up, E = extremity, LE = lower extremity, UE = upper extremity, HN = head and neck, abd = abdominal.

a

5 patients received intra operative radiotherapy.

b

Some patients received brachytherapy.

c

Number of patients receiving S + RT and RT alone.

*

Mean follow up.